Company / EPS (Diluted)
Chemed Corp. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$18.34
FY2025
5-year range
$16.53 / $19.89
FY2021-FY2025
Trend
-7.8%
vs FY2024
Sector context
#10 of 159
Health Care
What the data says
Among 159 Health Care companies, Chemed Corp. is in the top 6% for eps (diluted). EPS (Diluted) has fluctuated over the past 10 years, ranging from $5.86 in FY2017 to $19.89 in FY2024.
Based on SEC 10-K filings.
18.34 in FY2025 with a 5-year CAGR of -1.2%. Top quartile in the Health Care sector.
Improved from $17.93 to $18.34 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +3.5%
- 5-Year CAGR
- -1.2%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 159This company $18.34 Sector average $2.35
▼
+679.7% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 7.8% year-over-year.
- Ranks #10 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
- Lowest eps (diluted) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.34 | -7.8% |
| FY2024 | $19.89 | +10.9% |
| FY2023 | $17.93 | +8.5% |
| FY2022 | $16.53 | -1.9% |
| FY2021 | $16.85 | -13.5% |
| FY2020 | $19.48 | +46.4% |
| FY2019 | $13.31 | +8.8% |
| FY2018 | $12.23 | +108.7% |
| FY2017 | $5.86 | -9.6% |
| FY2016 | $6.48 | +2.4% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026